Interpace Diagnostics Group Inc (IDXG)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Interpace Diagnostics Group Inc (IDXG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011919
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interpace Diagnostics Group Inc (Interpace Diagnostics), formerly PDI Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathfinder platform; and ThyGenX and ThyraMIR, which collectively assess the risk of benign or malignant thyroid nodules, and minimizes unnecessary surgeries. It also provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers. The company’s labs are located in Pittsburgh, Pennsylvania, and New Haven, Connecticut. It serves its clients across the US. Interpace Diagnostics is headquartered in Parsippany, New Jersey, the US.

Interpace Diagnostics Group Inc (IDXG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Interpace Diagnostics Group Inc, Medical Devices Deals, 2011 to YTD 2017 8
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Interpace Diagnostics Raises up to USD4 Million in Private Placement of Shares and Warrants 10
PDI Files Registration Statement For Public Offering Of US$75 Million 11
Asset Transactions 12
Publicis Healthcare Communications Acquires Commercial Services Business of PDI 12
Interpace Diagnostics Group Inc – Key Competitors 13
Interpace Diagnostics Group Inc – Key Employees 14
Interpace Diagnostics Group Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Nov 18, 2016: Interpace Diagnostics Reports Third Quarter 2016 Results of Operations 16
Corporate Communications 17
Jan 17, 2017: Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Interpace Diagnostics Group Inc, Medical Devices Deals, 2011 to YTD 2017 8
Interpace Diagnostics Group Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Interpace Diagnostics Raises up to USD4 Million in Private Placement of Shares and Warrants 10
PDI Files Registration Statement For Public Offering Of US$75 Million 11
Publicis Healthcare Communications Acquires Commercial Services Business of PDI 12
Interpace Diagnostics Group Inc, Key Competitors 13
Interpace Diagnostics Group Inc, Key Employees 14
Interpace Diagnostics Group Inc, Subsidiaries 15

★海外企業調査レポート[Interpace Diagnostics Group Inc (IDXG)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Transmetro Corporation Limited
    Transmetro Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Transmetro Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bharat Sanchar Nigam Ltd:企業の戦略的SWOT分析
    Bharat Sanchar Nigam Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Castrol India Ltd (CASTROLIND):企業の財務・戦略的SWOT分析
    Summary Castrol India Ltd (Castrol India), a subsidiary of Castrol Limited, is an oil and gas company that manufactures, distributes and markets lubricant products. The company provides products such as lubricants, premium lubricating oils and greases, antifreeze and coolant, greases, engine oils, d …
  • ROSEN Swiss AG:企業の戦略的SWOT分析
    ROSEN Swiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Ocean Spray Cranberries Inc:企業の戦略・SWOT・財務情報
    Ocean Spray Cranberries Inc - Strategy, SWOT and Corporate Finance Report Summary Ocean Spray Cranberries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SeaBird Exploration PLC (SBX)-石油・ガス分野:企業M&A・提携分析
    Summary SeaBird Exploration Ltd (SeaBird) is an oil and gas company that provides marine 2D and 3D seismic data services. The company’s services include 2D seismic acquisition, 3D and 3D shallow water acquisition and source vessel. Its source vessels offers services such as conventional undershoots, …
  • Novacyt SA (ALNOV):企業の財務・戦略的SWOT分析
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • Ig Group Holdings Plc:企業の戦略・SWOT・財務分析
    Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hindustan Unilever Ltd (HINDUNILVR):企業の財務・戦略的SWOT分析
    Hindustan Unilever Ltd (HINDUNILVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Oragenics Inc (OGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Oragenics Inc (Oragenics) focuses on the development and commercialization of novel antibiotics against infectious disease that includes treatments for oral mucositis, healthcare associated infections, obesity and dental disorders. The company develops its product candidates based on various …
  • PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services which include phase I-IV study management, bioanalytical services, biometrics, clinical pharmacology, strategic solutions, post-marketing research …
  • GNC Holdings, Inc.:企業の戦略・SWOT・財務分析
    GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • NanoString Technologies Inc (NSTG):製薬・医療:M&Aディール及び事業提携情報
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion pane …
  • Hexicon AB:電力:M&Aディール及び事業提携情報
    Summary Hexicon AB (Hexicon) is a design and engineering company that manufactures and develops floating multi-platforms for offshore wind energy production. The company offers utilities to the developers for managing and utilizing the power of offshore wind and Hexicon platforms, and provides tank …
  • BioStem Technologies Inc (BSEM):製薬・医療:M&Aディール及び事業提携情報
    Summary BioStem Technologies Inc. (BioStem Technologies), formerly Caribbean International Holdings Inc., is a life sciences company that discovers, develops and manufactures pharmaceuticals and regenerative medicines. Through its subsidiaries, the company discovers, develops, produces and commercia …
  • Xcel Energy Inc (XEL)-石油・ガス分野:企業M&A・提携分析
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Chembond Chemicals Ltd (530871):企業の財務・戦略的SWOT分析
    Chembond Chemicals Ltd (530871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Energy Focus, Inc. (EFOI)-エネルギー分野:企業M&A・提携分析
    Summary Energy Focus, Inc. (Energy Focus) is a provider of energy efficient LED lighting products and technologies. The company, together with its subsidiaries, designs, develops, manufactures, markets, and installs energy-efficient lighting systems and solutions. Its military maritime products incl …
  • Fresenius Kabi AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Fresenius Kabi AG (Fresenius Kabi), a wholly owned subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. The company's product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and …
  • Deli Management, Inc. :企業の戦略・SWOT・財務情報
    Deli Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Deli Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆